A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Abroad (travel likely)RecruitingPHASE4
Conditions
Takayasu Arteritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Study leads
Lindi Jiang, PhD
Study Chair
Fudan University